BioSpace News Archive

Drug Development

Ampio Update of J.P. Morgan Meeting Events and Disease Modification Discussions

Ampio today reported a heavy schedule of meetings throughout the four-day conference, predominately with significant pharma companies discussing the successful clinical results of the company’s second pivotal phase III trial announced Dec. 14, 2017.

January 16, 2018
·
8 min read
ESSA Completes Second Tranche of Equity Offering, Raising Additional US$5M

Together with the initial closing on January 9, 2018 of the brokered equity offering and concurrent non-brokered private placement, the Company has raised total gross proceeds of approximately US$26M.

January 16, 2018
·
5 min read
Philips Debuts Fully Integrated Suite of Enhanced Patient Monitoring Solutions in U.S. Market

The latest offering features the IntelliVue X3, a transport monitor with intuitive smart-phone-style operation released in 2017.

January 16, 2018
·
4 min read
Regenexx Publishes New Research Findings That May Help Alleviate the Opioid Crisis

Regenexx today released new research that examines a more effective alternative for treating lower back pain to bypass the harmful effects of opioids and high dose steroids.

January 16, 2018
·
3 min read
Business

Illumina to Announce Fourth Quarter and Fiscal Year 2017 Financial Results on Tuesday, January 30, 2018

Illumina, Inc. today announced that it will issue results for fourth quarter and fiscal year 2017 following the close of market on Tuesday, January 30, 2018.

January 16, 2018
·
1 min read
Deals

ACM Global Laboratories Announces Strategic Acquisition of DrugScan and DSI Medical Services Growing International Laboratory Business

Rochester Regional Health announced that wholly-owned subsidiary, ACM Global Laboratories, has added to its portfolio with the strategic acquisition of Philadelphia-based DrugScan, Inc. and DSI Medical Services, Inc.

January 16, 2018
·
5 min read
Pediapharm Begins Trading on the OTCQB Venture Market

Pediapharm announce that the Company’s common shares begin trading today on the OTCQB Venture Market in the United States under the symbol “PDDPF”.

January 16, 2018
·
3 min read
Business

PPD and Quotient Sciences Form Innovative Partnership to Accelerate Pediatric Drug Development

The companies will jointly support pediatric drug development for clients from concept to market launch through a unique end-to-end service that will speed delivery of pediatric medicines.

January 16, 2018
·
5 min read
Drug Development

Athenex Receives Positive Feedback From FDA on the Design of Phase III Clinical Trial for Oraxol

The Oraxol Phase III clinical study is a randomized controlled international clinical trial investigating the superiority of Oraxol over intravenous paclitaxel in the treatment of patients with metastatic breast cancer.

January 16, 2018
·
5 min read
Business

Assure Holdings Appoints Peter Csapo as Chief Financial Officer

Former CFO Frank Iadipaolo will stay with the Company during an interim period to assist with the transition.

January 16, 2018
·
5 min read